[ad_1]
Swissmedic is testing the Pfizer vaccine on an ongoing basis. Swissmedic will handle the request more quickly. This is the case for all requests related to the corona virus. Swissmedic also increased its staff. However, Swissmedic emphasizes that they do not compromise care.
Pfizer’s vaccine is based on mRNA technology from biotechnology company BioNTech. The components of the mRNA contain the blueprint for the new corona virus. Based on this, human cells reproduce the protein that is characteristic of the virus. This simulates a corona virus infection in the human body. The immune system recognizes the foreign body and activates defense mechanisms such as the formation of antibodies.
If the real coronavirus enters the body of a vaccinated person, the antibodies already present recognize the virus, activate the immune system and neutralize the virus.
It is not the first request
In early October, competitor AstraZeneca submitted a vaccine request to Swissmedic. Meanwhile, AstraZeneca has already signed an agreement with the federal government that allows the delivery of 5.3 million doses of vaccines. (SDA / lui)
